RYTM   $90.51  3.58% Market Closed After Close 86.0 -4.98%

Rhythm Pharmaceuticals, Inc.

EMA (20): 2026-02-20 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-02-05 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2026-02-20 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type up and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -10.26%
EMA (20) date of signal Feb. 20, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -13.80%
EMA (50) date of signal Feb. 5, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -10.26%
EMA (100) date of signal Feb. 20, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -0.02%
RSI (14) date of signal March 3, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -8.70%
MACD date of signal Feb. 26, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield -3.44%
Stochastic date of signal Feb. 27, 2026, 3 a.m.
Updated March 4, 2026, 8:50 p.m.